Taysha Gene Therapies (TSHA) Competitors $2.90 +0.06 (+2.11%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$2.90 0.00 (0.00%) As of 05:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TSHA vs. HHH, KYMR, AMRX, XENE, ARWR, VKTX, CRNX, RARE, MOR, and NAMSShould you be buying Taysha Gene Therapies stock or one of its competitors? The main competitors of Taysha Gene Therapies include Howard Hughes (HHH), Kymera Therapeutics (KYMR), AMNEAL PHARMACEUTICALS (AMRX), Xenon Pharmaceuticals (XENE), Arrowhead Pharmaceuticals (ARWR), Viking Therapeutics (VKTX), Crinetics Pharmaceuticals (CRNX), Ultragenyx Pharmaceutical (RARE), MorphoSys (MOR), and NewAmsterdam Pharma (NAMS). Taysha Gene Therapies vs. Its Competitors Howard Hughes Kymera Therapeutics AMNEAL PHARMACEUTICALS Xenon Pharmaceuticals Arrowhead Pharmaceuticals Viking Therapeutics Crinetics Pharmaceuticals Ultragenyx Pharmaceutical MorphoSys NewAmsterdam Pharma Howard Hughes (NYSE:HHH) and Taysha Gene Therapies (NASDAQ:TSHA) are related companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, media sentiment, analyst recommendations, risk, institutional ownership, profitability and earnings. Is HHH or TSHA more profitable? Howard Hughes has a net margin of 12.85% compared to Taysha Gene Therapies' net margin of -1,144.97%. Howard Hughes' return on equity of 10.51% beat Taysha Gene Therapies' return on equity.Company Net Margins Return on Equity Return on Assets Howard Hughes12.85% 10.51% 3.15% Taysha Gene Therapies -1,144.97%-78.44%-44.82% Do analysts prefer HHH or TSHA? Howard Hughes presently has a consensus price target of $83.33, indicating a potential upside of 9.01%. Taysha Gene Therapies has a consensus price target of $8.29, indicating a potential upside of 185.71%. Given Taysha Gene Therapies' stronger consensus rating and higher possible upside, analysts plainly believe Taysha Gene Therapies is more favorable than Howard Hughes.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Howard Hughes 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Taysha Gene Therapies 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings & valuation, HHH or TSHA? Howard Hughes has higher revenue and earnings than Taysha Gene Therapies. Taysha Gene Therapies is trading at a lower price-to-earnings ratio than Howard Hughes, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHoward Hughes$1.75B2.59$200.55M$4.5716.73Taysha Gene Therapies$8.10M97.69-$89.30M-$0.34-8.53 Do insiders & institutionals hold more shares of HHH or TSHA? 93.8% of Howard Hughes shares are owned by institutional investors. Comparatively, 77.7% of Taysha Gene Therapies shares are owned by institutional investors. 48.0% of Howard Hughes shares are owned by company insiders. Comparatively, 3.8% of Taysha Gene Therapies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more risk and volatility, HHH or TSHA? Howard Hughes has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Comparatively, Taysha Gene Therapies has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500. Does the media refer more to HHH or TSHA? In the previous week, Howard Hughes had 7 more articles in the media than Taysha Gene Therapies. MarketBeat recorded 10 mentions for Howard Hughes and 3 mentions for Taysha Gene Therapies. Howard Hughes' average media sentiment score of 1.43 beat Taysha Gene Therapies' score of 1.28 indicating that Howard Hughes is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Howard Hughes 7 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Taysha Gene Therapies 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryHoward Hughes beats Taysha Gene Therapies on 12 of the 16 factors compared between the two stocks. Get Taysha Gene Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for TSHA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TSHA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TSHA vs. The Competition Export to ExcelMetricTaysha Gene TherapiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$774.74M$4.22B$5.77B$9.76BDividend YieldN/A1.29%6.66%4.49%P/E Ratio-8.5311.1082.3426.60Price / Sales97.6915.28502.89158.84Price / CashN/A7.4225.7028.92Price / Book3.194.8110.916.56Net Income-$89.30M-$109.62M$3.28B$266.04M7 Day Performance2.47%0.25%0.09%-0.89%1 Month Performance7.01%16.60%8.93%4.34%1 Year Performance40.10%30.27%51.81%24.06% Taysha Gene Therapies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TSHATaysha Gene Therapies1.8056 of 5 stars$2.90+2.1%$8.29+185.7%+40.8%$774.74M$8.10M-8.53180News CoverageHHHHoward Hughes1.8202 of 5 stars$75.11-0.5%$80.33+7.0%+3.4%$4.48B$1.75B16.44608News CoveragePositive NewsKYMRKymera Therapeutics3.4789 of 5 stars$41.82-5.2%$59.11+41.3%-6.5%$3.15B$47.07M-12.05170News CoveragePositive NewsAMRXAMNEAL PHARMACEUTICALS3.0472 of 5 stars$9.28-3.2%$11.60+25.0%+12.4%$3.01B$2.79B928.938,100Positive NewsXENEXenon Pharmaceuticals2.6522 of 5 stars$38.14-1.8%$53.20+39.5%-3.3%$2.99B$9.43M-10.74210News CoveragePositive NewsAnalyst ForecastOptions VolumeARWRArrowhead Pharmaceuticals4.2014 of 5 stars$20.71-2.9%$43.14+108.3%+21.3%$2.95B$3.55M-16.18400News CoverageAnalyst ForecastVKTXViking Therapeutics4.2605 of 5 stars$25.85-0.6%$86.92+236.3%-54.1%$2.92BN/A-16.9020Positive NewsAnalyst RevisionCRNXCrinetics Pharmaceuticals3.7996 of 5 stars$30.09-2.7%$68.86+128.8%-33.4%$2.91B$1.39M-7.32210News CoveragePositive NewsRAREUltragenyx Pharmaceutical4.5048 of 5 stars$29.27-1.7%$81.50+178.4%-43.4%$2.87B$560.23M-5.291,294MORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730NAMSNewAmsterdam Pharma3.8219 of 5 stars$24.70-1.2%$41.55+68.2%+56.4%$2.82B$45.56M-15.254News Coverage Related Companies and Tools Related Companies HHH Alternatives KYMR Alternatives AMRX Alternatives XENE Alternatives ARWR Alternatives VKTX Alternatives CRNX Alternatives RARE Alternatives MOR Alternatives NAMS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TSHA) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Taysha Gene Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Taysha Gene Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
